| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/29/2000 | EP0886526A4 Protection of hemopoietic cells |
| 03/29/2000 | EP0783320A4 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 03/29/2000 | EP0777689B1 Use of cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 03/29/2000 | EP0697891B1 Polyoxime compounds and their preparation |
| 03/29/2000 | EP0611302B1 Receptors for treating late phase inflammatory responses |
| 03/29/2000 | EP0598133B1 Remedy for wound |
| 03/29/2000 | CN1249002A Component of bromelain |
| 03/29/2000 | CN1248921A Methods of therapeutic administration of anti-CD40L compounds |
| 03/29/2000 | CN1248920A Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 03/29/2000 | CN1248917A Method of treating prostatic diseases using active vitamin danalogues |
| 03/29/2000 | CN1248914A Pharmaceutical composition |
| 03/29/2000 | CN1248911A Opthalmic non-irritating iodine medicament and method |
| 03/29/2000 | CN1050748C Preparation process of surface anesthesia film |
| 03/28/2000 | US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 03/28/2000 | US6043357 Stability, efficiency; treating human immuno deficiency viurs |
| 03/28/2000 | US6043348 Antibody recognizing a small subset of human hematopoietic cells |
| 03/28/2000 | US6043347 Compositions and methods for treating viral infections |
| 03/28/2000 | US6043346 Antibody that binds to a tub polypeptide |
| 03/28/2000 | US6043345 Isolated functional immunoglobulin e having an epsilon constant region wherein ch4'is spliced directly to ch5; for use in immune hypersensitivity diagnosis and treatment |
| 03/28/2000 | US6043344 Human CTLA-8 and uses of CTLA-8-related proteins |
| 03/28/2000 | US6043343 Amino acid sequence; for diagnosis and prevention of cancer and tumors; anticarcinogenic/antitumor agents; for screening compounds which bind to polypeptide |
| 03/28/2000 | US6043342 Human protein whose presence indicates ongoing neoplastic development within cells and tissues of epithelial cell origin and thus is a reliable and reproducible biochemical marker |
| 03/28/2000 | US6043341 Cyclic peptide antifungal agents |
| 03/28/2000 | US6043340 Synthetic peptide having amino acid sequence encoded by genetic suppressor element isolated from kinesin gene; for investigating drug resistance |
| 03/28/2000 | US6043339 Heterologous complex of polypeptides or nucleic acids which are linked to an importation competent signal peptide and to a nuclear localization peptide; for peptide and gene therapy and antisense agents |
| 03/28/2000 | US6043278 Perfluoralkyl substituted metallo-beta-lactamase inhibitors |
| 03/28/2000 | US6043268 Agent for treatment of viral infections |
| 03/28/2000 | US6043251 Treating muscular and nervous system disorders; including an effective amount of 2-amino-6-trifluoromethoxybenzothiazole |
| 03/28/2000 | US6043233 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 03/28/2000 | US6043232 Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs |
| 03/28/2000 | US6043224 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 03/28/2000 | US6043223 Enhanced opening of abnormal brain tissue capillaries |
| 03/28/2000 | US6043222 Two new human DnaJ-like proteins |
| 03/28/2000 | US6043221 Method for preventing and treating hearing loss using a neuturin protein product |
| 03/28/2000 | US6043220 Threonine-containing protegrins |
| 03/28/2000 | US6043219 Broad spectrum chemotherapeutic peptide |
| 03/28/2000 | US6043217 Antibacterial activity against methicillin-resistant staphylococcus aureus (mrsa). |
| 03/28/2000 | US6043216 An autocrine crystal adhesion inhibitor is an anionic, sialic acid-containing glycoprotein secreted by kidney epithelial cells that blocks adhesion of calcium oxalate monohydrate (com) crystals to the cell surface. |
| 03/28/2000 | US6043215 Preparation of factor IX |
| 03/28/2000 | US6043214 Method for producing powder formulation comprising an insulin |
| 03/28/2000 | US6043213 Drug composition comprising albumin as active ingredient |
| 03/28/2000 | US6043212 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 03/28/2000 | US6043211 Adding to a first protein a peptide analogue of a phosphorylated region, whereupon the binding of said first protein to said second protein is inhibited |
| 03/28/2000 | US6043094 Therapeutic liposome composition and method |
| 03/28/2000 | US6043090 Compound of 8 to 30 nucleotides targeted to a 3' or 5' untranslated region or coding region of nucleic acid which encodes human serine/threonine kinase; diagnosis, therapy, and prophylaxis of related diseases; anticancer agents |
| 03/28/2000 | US6043085 Nucleotide and amino acid sequences; for treatment of infections/bactericides |
| 03/28/2000 | US6043084 Nucleotide sequences which encode a cancer associated antigen |
| 03/28/2000 | US6043083 Inhibitors of the JNK signal transduction pathway and methods of use |
| 03/28/2000 | US6043082 Two genetic constructs encoding chimeric proteins, each with ligand binding domain to complex with the other protein; one protein also with domain which induces biological process, the other having intracelluar targeting domain; gene therapy |
| 03/28/2000 | US6043081 Expression vectors encoding recombinant proteins comprising a VPR/VPX virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
| 03/28/2000 | US6043078 Adding amylase to a concentration greater than 1 unit per milliliter enzyme activity to aqueous solution of gelatin, photodeveloper, or photoprocessing chemicals; to reduce waste and spoilage |
| 03/28/2000 | US6043077 Directed aganist specific nucleotide sequences to inhibit replication, infectivity, or gene expression of the virus; for prevention or viricides with side effect reduction |
| 03/28/2000 | US6043073 Phospholipase D polypeptide and DNA sequences |
| 03/28/2000 | US6043071 GlmU |
| 03/28/2000 | US6043069 Catalytic antibodies and a method of producing same |
| 03/28/2000 | US6043062 Constitutively active phosphatidylinositol 3-kinase and uses thereof |
| 03/28/2000 | US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders |
| 03/28/2000 | US6043054 Polynucleotides encoding a novel GABA BP polypeptide |
| 03/28/2000 | US6043053 Wnt-3 polynucleotides |
| 03/28/2000 | US6043052 Nucleotide and amino acid sequences of g protein coupled receptor; for diagnosis and treatment of related diseases; anticarcinogenic/antidiabetic/antiulcer agents; antidepressants; hypotensive/hypertensive agents |
| 03/28/2000 | US6042848 Enhancement of antimicrobial peptide activity by metal ions |
| 03/28/2000 | US6042846 Resistant to nuclease hydrolysis; efficiency |
| 03/28/2000 | US6042837 Administering bifunctional crosslinker comprising staphylococcal enterotoxin a to living body having target cell expressing mhc class ii antigen to direct cytotoxic t cells to lyse target cell |
| 03/28/2000 | US6042830 Viral agent associated with mystery swine disease |
| 03/28/2000 | US6042828 Humanized antibodies to ganglioside GM2 |
| 03/28/2000 | US6042827 Anti-idiotypic antibody induction of anti-tumor response |
| 03/28/2000 | US6042826 Administering intrathecally or intralesionally a therapeutically effective amount of a fas-crosslinking component selected from an agonsit antihuman fas monoclonal antibody, anti-human fas bid fragments, or soluble fas-ligand |
| 03/28/2000 | US6042825 A parasitic helminth asparaginase proteins; parasitic helminth asparaginase nucleic acid molecules that codes such asparaginase proteins |
| 03/28/2000 | US6042824 Combining the substrate and a crosslinked enzyme crystal formulation containing a crosslinked enzyme and a surfactant which acts upon the substrate in presence of organic solvent or aqueous-organic solvent to form a product |
| 03/28/2000 | US6042823 Ingesting an enzyme selected from amylase and invertase capable of acting in the living body together with a food material containing a substrate for forming oligosaccharide to prevent weight gain, diabetes, gastrointestinal disorders |
| 03/28/2000 | US6042822 Mixture of alpha-interferon-conjugate positional isomers comprises an alpha-interferon covalently conjugated to a non-antigenic alkyl terminated polyalkylene oxide at a histidine residue on alpha interferon |
| 03/28/2000 | US6042821 Treating sepsis using chemokines which are a protein or polypeptide |
| 03/28/2000 | CA2245903A1 Use of pex in the treatment of metabolic bone diseases |
| 03/28/2000 | CA2164712C Trifunctional antithrombin and antiplatelet peptides |
| 03/28/2000 | CA2006658C An anticoagulant substance obtained from urine |
| 03/28/2000 | CA2004885C Anticoagulant peptides |
| 03/28/2000 | CA2004739C Hemostatic collagen paste composition |
| 03/28/2000 | CA2002144C Method of preventing or reducing eosinophilia |
| 03/28/2000 | CA1340935C Fc gamma receptor |
| 03/26/2000 | CA2403011A1 Apparatus for electrical moxibustion using the extract |
| 03/26/2000 | CA2283350A1 Method of preparing pharmaceutical artemisia extract and apparatus for electrical moxibustion using the extract |
| 03/23/2000 | WO2000015843A1 Genetic suppression therapy |
| 03/23/2000 | WO2000015826A2 Leptin induced genes |
| 03/23/2000 | WO2000015822A1 Methods for treatment of degenerative retinal diseases |
| 03/23/2000 | WO2000015807A1 Method for down-regulating osteoprotegerin ligand activity |
| 03/23/2000 | WO2000015806A1 Atp synthase subunit homolog |
| 03/23/2000 | WO2000015805A1 Use of protein kinase kiaa0551 as pharmaceutical |
| 03/23/2000 | WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 03/23/2000 | WO2000015800A2 Rac-like genes and methods of use |
| 03/23/2000 | WO2000015799A2 Rna-associated proteins |
| 03/23/2000 | WO2000015798A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 03/23/2000 | WO2000015797A2 Compositions and methods for the treatment of immune related diseases |
| 03/23/2000 | WO2000015794A1 Human cell junction pdz protein |
| 03/23/2000 | WO2000015793A2 Human gpcr proteins |
| 03/23/2000 | WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 03/23/2000 | WO2000015790A2 Leptin induced genes |
| 03/23/2000 | WO2000015788A2 Dna sequence encoding oncofetal ferritin protein |
| 03/23/2000 | WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 03/23/2000 | WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 03/23/2000 | WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN |